...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Financials

JJ - Zenith actually is a public company so they file their financials on SEDAR. Because they are a public company is why they qualify for registered accounts. The financials we are waiting for are year-end so are audited. That takes longer and if true to past form, should be out later this month as Bear posted.

Share
New Message
Please login to post a reply